WST

West Pharmaceutical Services
D

WST

Arincen83/100B
413.00
USD
1.73
(0.42%)
Market Open
Last updated: · Delayed 15 min
Fair value379.45Plus+9%222Price 413.00531
Q4 FY2026 · Earnings report
EPS estimate 2.27Revenue estimate 825.22M
OverviewFinancialsForecastEarningsDividendsCompany

West Pharmaceutical Services net income 1985–2026

West Pharmaceutical Services earned 214.00M USD in Q3 FY2026, the three months to 30 September 2026, up 52.9% on the same quarter a year before. West Pharmaceutical Services's net income over the last twelve months was 638.90M USD, up 29.9% on the twelve months before. In fiscal year 2025 it earned 493.70M USD, up 0.2% on the year before.

Last updated 9 Nov 2026 · Next report 11 Feb 2027

Net income

Net income · +17.8% a year over 10 yearsNet margin

Growth

Fiscal yearPeriod endingNet incomeGrowthNet marginRevenue
TTM30 Sept 2026638.90M+29.94%18.81%3.40B
FY202531 Dec 2025493.70M+0.20%16.06%3.07B
FY202431 Dec 2024492.70M-16.97%17.03%2.89B
FY202331 Dec 2023593.40M+1.28%20.11%2.95B
FY202231 Dec 2022585.90M-11.47%20.30%2.89B
FY202131 Dec 2021661.80M+91.16%23.38%2.83B
FY202031 Dec 2020346.20M+43.24%16.13%2.15B
FY201931 Dec 2019241.70M+16.82%13.11%1.84B
FY201831 Dec 2018206.90M+37.29%12.04%1.72B
FY201731 Dec 2017150.70M+4.94%9.42%1.60B
FY201631 Dec 2016143.60M+50.21%9.52%1.51B
FY201531 Dec 201595.60M-24.78%6.84%1.40B
FY201431 Dec 2014127.10M+13.18%8.94%1.42B
FY201331 Dec 2013112.30M+39.16%8.21%1.37B
FY201231 Dec 201280.70M+6.89%6.37%1.27B
FY201131 Dec 201175.50M+15.62%6.33%1.19B
FY201031 Dec 201065.30M-10.06%5.91%1.10B
FY200931 Dec 200972.60M-15.58%6.88%1.06B
FY200831 Dec 200886.00M+21.64%8.18%1.05B
FY200731 Dec 200770.70M+5.37%6.93%1.02B
FY200631 Dec 200667.10M+47.15%7.35%913.30M
FY200531 Dec 200545.60M+135.05%6.52%699.70M
FY200431 Dec 200419.40M-39.18%3.58%541.60M
FY200331 Dec 200331.90M+73.37%6.50%490.70M
FY200231 Dec 200218.40M—4.38%419.70M
FY200131 Dec 2001-5.20M-425.00%-1.31%396.90M
FY200031 Dec 20001.60M-95.87%0.37%430.10M
FY199931 Dec 199938.70M+477.61%8.25%469.10M
FY199831 Dec 19986.70M-84.91%1.49%449.70M
FY199731 Dec 199744.40M+170.73%9.81%452.50M
FY199631 Dec 199616.40M-42.86%3.57%458.80M
FY199531 Dec 199528.70M+5.13%6.95%412.90M
FY199431 Dec 199427.30M+16.17%7.48%365.10M
FY199331 Dec 199323.50M+19.29%6.74%348.70M
FY199231 Dec 199219.70M—5.82%338.20M
FY199131 Dec 1991-8.50M-297.67%-2.58%329.60M
FY199031 Dec 19904.30M-79.23%1.33%323.20M
FY198931 Dec 198920.70M+18.97%6.71%308.70M
FY198831 Dec 198817.40M+27.01%6.04%288.20M
FY198731 Dec 198713.70M-19.41%5.41%253.30M
FY198631 Dec 198617.00M+13.33%7.22%235.60M
FY198531 Dec 198515.00M—7.89%190.10M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about West Pharmaceutical Services's profit

Source: Financial Modeling Prep